Gini F. Fleming

Gini Fleming practices at Comer Children's Hospital - Hyde Park in Chicago, Illinois.

Gini Fleming's NPI, 1407918964, was assigned on December 14, 2006. Gini Fleming graduated from University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb) in 1985. Gini Fleming holds Illinois license 036075100.

Gini Fleming's primary practice is Comer Children's Hospital - Hyde Park, at 5721 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Gini Fleming's primary practice is Comer Children's Hospital - Hyde Park in Chicago, Illinois. Gini Fleming is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Gini Fleming to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Gini Fleming practices. Vendor and product names are available with a free account.

Hematology and oncology is Gini Fleming's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Gini Fleming is licensed in Illinois.

CMS data shows 406 Medicare services from Gini Fleming across 9 procedure codes in 2024, for 127 Medicare patients. Medicare paid $29,682 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 127 Medicare patients who saw Gini Fleming in 2024. The largest group is 65 to 74, with 76 patients. 75% of them have cancer, and 71% have high blood pressure. 20% are also on Medicaid. Their average risk score is 2.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Gini Fleming's median patient age at 71, with 79% women.

In 2024, Gini Fleming wrote 251 Medicare Part D claims for 52 patients. 86% of them were for generic drugs. CMS names the drug for 121 of them, across 6 drugs with 11 or more claims each, at $1,667 in total drug cost. In 2023, CMS named 152 claims across 7 drugs.

Gini Fleming accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Gini Fleming as offering telehealth.

Dmand AI links 90 papers to Gini Fleming, published from 2017 to 2025. 2019 was the busiest year, with 15. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms and Ovarian Neoplasms. Gini Fleming has published most often in J Clin Oncol. Gini Fleming's most frequent co-authors are Rita Nanda, Elizabeth Mary Swisher and John W. Moroney.

CMS Open Payments shows 10 general payments to Gini Fleming from 7 drug and device companies from 2017 to 2021. Consulting fees make up the largest share, 67% of the total. GlaxoSmithKline, LLC. paid the most, $6,713. It also lists 4 research payments totaling $195 from 2019 to 2025, naming 2 clinical trials.

Gini Fleming graduated from University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb) in 1985.